US SB2909 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on May 22 2018 - 25% progression, died in committee
Action: 2018-05-22 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 22 2018 - 25% progression, died in committee
Action: 2018-05-22 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Assessing Barriers to Opioid Use Disorder Treatment Act This bill requires the Government Accountability Office to report on barriers to the provision of medication used to treat substance use disorders (e.g., buprenorphine) under Medicaid distribution models (e.g., provider purchasing, storage, and administration of medications).
Title
Assessing Barriers to Opioid Use Disorder Treatment Act
Sponsors
| Sen. Dean Heller [R-NV] | Sen. Michael Bennet [D-CO] | Sen. Joe Manchin [D-WV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-05-22 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
SB3120 (Related) 2018-06-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 484.
Subjects
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government studies and investigations
Health
Medicaid
Prescription drugs
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government studies and investigations
Health
Medicaid
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/senate-bill/2909/all-info |
| Text | https://www.congress.gov/115/bills/s2909/BILLS-115s2909is.pdf |
